Koneksa Services
Turning complex data into confident decisions, our biostatistics services align analytical strategy with clinical intent to deliver interpretable, defensible evidence throughout the trial.
Biostatistics Designed to Inform Clinical and Regulatory Decisions
Biostatistics shapes how clinical trial data is framed, interpreted, and ultimately used to inform decisions. Analytical choices determine whether results are understandable, defensible, and aligned with the questions a study is designed to answer.
Koneksa approaches biostatistics as a decision-shaping scientific discipline. By aligning analytical strategy with disease biology, study objectives, and decision needs, we support partners and sponsors in drawing conclusions that are clinically meaningful and defensible under regulatory scrutiny.
A Different Approach to Biostatistics
Analytical Strategy, Not Statistical Convention
Statistical approaches are tailored to study objectives, endpoints, and decision needs, ensuring methods serve interpretation and confidence rather than rigid convention.
Integrated Biostatistics and Programming
Biostatistics and statistical programming operate as a single analytical function, enabling deep understanding of data behavior, assumptions, and trial context throughout execution.
Insight-Focused, Submission-Ready Analytics
Integrate traditional clinical measures such as lab tests, imaging, and functional assessments—into a unified data stream alongside digital biomarkers to create a holistic, multimodal evidence package.
Flexible Engagement Without Fragmentation
Partners and sponsors engage Koneksa through full-service delivery, functional leadership, or consultative support without sacrificing analytical continuity or scientific intent.
Built on Proven Expertise and Infrastructure
Koneksa maintains a global biostatistics organization with experience spanning Phase I–IV clinical development, supporting programs across a number of therapeutic areas, including:
Dermatology
Neuroscience
Oncology
Opthalmology
Pediatrics
Rare Disease
Medical Devices
Our biostatistics delivery is supported by validated, industry-standard analytical environments and global SOPs, including:
- Statistical analysis and programming in SAS® v9.2,
- Trial design and sample size determination with nQuery®
- CDISC conformance review using Pinnacle 21®.
Outputs are aligned with submission requirements, including SDTM, ADaM, and Define.xml.
Biostatistics
That Enables Confident
Evidence
Insight-focused. Submission-ready. Decision-driven.
When biostatistics is grounded in analytical intent and closely integrated with the broader trial context, it becomes a driver of clarity rather than uncertainty. Statistical approaches support not only analysis, but decision-relevant understanding, helping teams see what the data truly show and how confidently conclusions can be drawn.
By aligning analytical strategy with study objectives, regulatory expectations, and evolving data behavior, biostatistics supports evidence that is both interpretable and submission-ready. The result is greater confidence in clinical conclusions and fewer surprises as programs advance.
